Generic and innovative drugs market in Poland 2017

Market analysis and development forecasts for 2017-2022

View Leaflet

Industry Report

Generic and innovative drugs market in Poland 2017

Market analysis and development forecasts for 2017-2022

This product is also available in Polish

Product details

Price:

2 400

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Generic and innovative drugs market in Poland 2017

Market analysis and development forecasts for 2017-2022

View Leaflet

The publication describes the current situation in the sector of generic and innovative drugs, binding legal and pricing regulations, changes to the reimbursement lists and their impact on the market of original drugs and their equivalents, as well as bestselling products in the Polish pharmaceutical market in the analysed groups. In addition, the report presents the value of the generic drugs market and the entire pharma market, their growth potential and forecasts for 2017-2022 which take into consideration expected trends and changes to pricing and reimbursement policies. Profiles of the key manufacturers of generic and innovative drugs will be valuable information, in particular when conducting competitive analysis or searching for business partners.

Subscription: 12 months
Publication date: September 2016
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharma
Country: Poland
Pages: 349

Do you need assistance?

Phone: +48 12 340 51 30

Email: info@pmrcr.com

Description

Description

The publication describes the current situation in the sector of generic and innovative drugs, binding legal and pricing regulations, changes to the reimbursement lists and their impact on the market of original drugs and their equivalents, as well as bestselling products in the Polish pharmaceutical market in the analysed groups. In addition, the report presents the value of the generic drugs market and the entire pharma market, their growth potential and forecasts for 2017-2022 which take into consideration expected trends and changes to pricing and reimbursement policies. Profiles of the key manufacturers of generic and innovative drugs will be valuable information, in particular when conducting competitive analysis or searching for business partners.


What is the content of the report?

What is the content of PMR’s report on generic and innovative drugs market in Poland?

 

This comprehensive study includes all relevant topics and statistical data pertaining to the market for generic and innovative drugs in Poland, such as:

  • value of the overall market and each of its key segments
  • forecasts for the development of this market and its segments from 2016 until 2021 
  • share of the Polish pharmaceutical market occupied by the generic and innovative drugs segment 
  • trends and events currently affecting conditions on the Polish market for innovative and generic medicines
  • Rankings of the largest manufacturers of generic and innovative drugs offering products on the Polish market
  • profiles of the largest manufacturers of generic and innovative drugs that feature key characteristics of the company, descriptions of growth strategies, and explanations of current and planned research and development activities
  • national pricing policy with regard to drugs sold in the pharmacy and hospital distribution chains
  • recent and anticipated changes in the reimbursement lists
  • listings of best-selling generic and innovative medications.
  • rules governing the reimbursement of medicines
  • procedure for obtaining the status of a reimbursed drug 
  • national expenditures on reimbursement 
  • changes made to lists of reimbursed drugs
  • expiration of patents
  • periods of data exclusivity
  • changes expected to affect the market in the coming years.

Who benefits from the analysis?

Who benefits from the analysis?

 

The report is recommended to management staff and specialists responsible for strategy and business development, as well as sales and marketing from the following types of companies:

  • manufacturers and distributors of generic drugs, including pharmacies, pharmaceutical wholesalers and hospitals
  • manufacturers and distributors of innovative drugs, including pharmacies, pharmaceutical wholesalers and hospitals
  • companies involved in advertising and research for the pharmaceutical industry
  • entities entering or planning to enter the pharmaceutical market in Poland
  • consulting and research companies, government and academic institutions that monitor the segment of innovative and generic drugs.

 

Why to buy the report?

Why to buy the report?

 

Information contained in the report will be crucial when implementing the following projects:

 

  • estimating the growth potential of the generic and innovative drugs market in Poland with a view to making investment decisions and elaborating development strategies in the Polish market owing to original forecasts prepared by the team of PMR’s market analysts and econometricians
  • defining the portfolio of manufactured innovative and generic drugs, identification of opportunities and threats
  • expanding the product portfolio by drug distributors
  • elaborating the market entry strategy by new market participants or business development strategy by existing market players
  • conducting analysis of companies operating in the pharmaceutical market with a view to monitoring competition or seeking new business partners
  • tracking legislative changes, key events and new trends regarding the Polish generic and innovative drugs market, preparing to a flexible response to them
  • supporting business plans and other activities during presentations for a company management board with reliable data and conclusions
  • useful collection of data and forecasts necessary for important corporate steps, such as performing mergers and acquisitions in the pharmaceutical market in Poland or getting listed on the stock exchange.

 

Table of Contents

Table of Contents

Graphs and Tables

Graphs and Tables

Infographic

Infographic

Product details

Price:

2 400

Select languages:

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Subscription: 12 months
Publication date: December 2017
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Healthcare
Country: Poland

Do you need assistance?

Phone: +48 12 340 51 30

Email: support@pmrcorporate.com

Clients' Testimonials

 We are a long-standing subscriber of PMR’s information services, and specifically its pharmaceutical and healthcare market news bulletins.

We appreciate the reliability of the information provided,and the high standards of data analysis offered by PMR.    

Prezes Zarządu

PHOENIX Pharma Polska Sp. z o. o

I have been using PMR reports in my daily work for over 3 years. They are a source of consolidated knowledge based on the relevant indicators. At the same time I value our cooperation as an expert in the Health Care market in Poland. Your forecasts are important to us when working on marketing and promotional strategies.

Head of Sales and Marketing

Roche Diagnostic Polska Sp. z o.o.

Standard - license option entitles Client to make use of the product for a maximum of 2 persons indicated in the purchase process

Standard Plus - license option entitles Client to make use of the product for between 3 and 9 persons indicated in the purchase process

Corporate - license option entitles Client to make use of the product for between 10 and an unlimited number of persons indicated in the purchase process